AAM
ABBV icon

Alphadyne Asset Management’s AbbVie ABBV Stock Holding History

Alphadyne Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$857K Buy
+3,940
New +$874K 0.01% 599
2023
Q4 		– Sell
-10,459
Closed -$1.56M – 30
2023
Q3 		$1.56M Buy
10,459
+4,960
+90% +$728K 0.12% 123
2023
Q2 		$741K Buy
+5,499
New +$806K 0.09% 71

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alphadyne Asset Management's ABBV Position: Q1 2026 in Review

Alphadyne Asset Management opened a new position in AbbVie (ABBV) in Q1 2026: 3,940 shares worth $857K. The stake represents 0.01% of the portfolio and ranks #599 among its holdings. This is a return to the name: Alphadyne Asset Management previously reported a position in ABBV as recently as Q3 2023.

Alphadyne Asset Management first reported a position in ABBV in Q2 2023 and has held it in 3 quarters since. The position peaked at $1.56M in Q3 2023. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Alphadyne Asset Management held 3,940 shares of AbbVie worth $857K as of Q1 2026.
  • AbbVie was a new Alphadyne Asset Management position in Q1 2026.
  • AbbVie made up 0.01% of Alphadyne Asset Management's portfolio in Q1 2026, its #599 holding.
  • Alphadyne Asset Management first reported a position in AbbVie in Q2 2023 and has held it in 3 quarters since.
  • Alphadyne Asset Management's AbbVie position peaked at $1.56M in Q3 2023.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Alphadyne Asset Management's 13F filing for Q1 2026, filed 15 May 2026.